High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury.

Eur J Pharmacol 2004 Aug;497(1):29-33

Centre de Recherche Pierre Fabre, 17 Avenue Jean Moulin, 81100 Castres, France.

The selective, high-efficacy 5-HT(1A) receptor agonist, (3-chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl]piperidin-1-yl]-methanone (F 13640) has been reported to produce long-term analgesia in rodent models of chronic nociceptive and neuropathic pain; it also preempts allodynia following spinal cord injury. Here, rats underwent spinal cord injury, fully developed allodynia, and were infused with saline or 0.63 mg/day of F 13640 for 56 days. Infusion was then discontinued, and further assessments of allodynia (vocalization threshold to von Frey filament stimulation, responses to brush and cold) were conducted for another 70 days. F 13640-induced analgesia persisted during this post-treatment period. The data offer initial evidence that high-efficacy 5-HT(1A) receptor activation produces an unprecedented curative-like action on pathological pain.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejphar.2004.06.026DOI Listing
August 2004
7 Reads

Publication Analysis

Top Keywords

cord injury
12
spinal cord
12
5-ht1a receptor
12
high-efficacy 5-ht1a
12
receptor activation
8
curative-like action
8
discontinued assessments
4
days infusion
4
infusion discontinued
4
allodynia vocalization
4
von frey
4
threshold von
4
vocalization threshold
4
13640 days
4
assessments allodynia
4
saline 063
4
underwent spinal
4
rats underwent
4
injury rats
4
allodynia spinal
4

Similar Publications